CORRESP Filing
Xtant Medical Holdings, Inc.
Date: May 15, 2025 · CIK: 0001453593 · Accession: 0001641172-25-010901
AI Filing Summary & Sentiment
File numbers found in text: 333-287192
Show Raw Text
CORRESP 1 filename1.htm 664 Cruiser Lane Belgrade, Montana 59714 (406) 388-0480 May 15, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Jason Drory Re: Xtant Medical Holdings, Inc. Registration Statement on Form S-1 Filed May 12, 2025 File No. 333-287192 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Xtant Medical Holdings, Inc. (the "Company") hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:01 p.m., Eastern Time, on May 19, 2025, or as soon thereafter as is practicable. The Company requests that it be notified of such effectiveness by a telephone call to Emily Humbert of Fox Rothschild LLP at (612) 607-7076. Thank you for your assistance in this matter. Should you have any questions, please call Ms. Humbert. Very truly yours, XTANT MEDICAL HOLDINGS, INC. /s/ Sean E. Browne Sean E. Browne President and Chief Executive Officer cc: Amy E. Culbert, Esq. Emily Humbert, Esq.